Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4351 AL 4365

Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid

Bloniecki V, Aarsland D, Blennow K, Cummings J, Falahati F, Winblad B, Freund-Levi Y.

J Alzheimers Dis. 2017;57(2):387-393. doi: 10.3233/JAD-160758.

A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling

Hampel H, O'Bryant SE, Durrleman S, Younesi E, Rojkova K, Escott-Price V, Corvol JC, Broich K, Dubois B, Lista S; Alzheimer Precision Medicine Initiative.

Climacteric. 2017 Apr;20(2):107-118. doi: 10.1080/13697137.2017.1287866. Epub 2017 Feb 9.

Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid

Enche Ady CNA, Lim SM, Teh LK, Salleh MZ, Chin AV, Tan MP, Poi PJH, Kamaruzzaman SB, Abdul Majeed AB, Ramasamy K.

J Neurosci Res. 2017 Oct;95(10):2005-2024. doi: 10.1002/jnr.24048. Epub 2017 Mar 16.

Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial

Craft S, Claxton A, Baker LD, Hanson AJ, Cholerton B, Trittschuh EH, Dahl D, Caulder E, Neth B, Montine TJ, Jung Y, Maldjian J, Whitlow C, Friedman S.

J Alzheimers Dis. 2017;57(4):1325-1334. doi: 10.3233/JAD-161256.

Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies

Shinohara M, Tachibana M, Kanekiyo T, Bu G.

J Lipid Res. 2017 Jul;58(7):1267-1281. doi: 10.1194/jlr.R075796. Epub 2017 Apr 4.

A phase 3 trial of IV immunoglobulin for Alzheimer disease

Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, Szabo P, Gelmont DM, Fritsch S, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2017 May 2;88(18):1768-1775. doi: 10.1212/WNL.0000000000003904. Epub 2017 Apr 5.

Aβ levels in the jugular vein and high molecular weight Aβ oligomer levels in CSF can be used as biomarkers to indicate the anti-amyloid effect of IVIg for Alzheimer's disease

Kasai T, Kondo M, Ishii R, Tanaka A, Ataka S, Shimada H, Tomiyama T, Mori H, Taylor M, Allsop D, Nakagawa M, Mizuno T, Tokuda T.

PLoS One. 2017 Apr 10;12(4):e0174630. doi: 10.1371/journal.pone.0174630. eCollection 2017.

N-glycan and Alzheimer's disease

Kizuka Y, Kitazume S, Taniguchi N.

Biochim Biophys Acta Gen Subj. 2017 Oct;1861(10):2447-2454. doi: 10.1016/j.bbagen.2017.04.012. Epub 2017 Apr 29.

Bryostatin Effects on Cognitive Function and PKCɛ in Alzheimer's Disease Phase IIa and Expanded Access Trials

Nelson TJ, Sun MK, Lim C, Sen A, Khan T, Chirila FV, Alkon DL.

J Alzheimers Dis. 2017;58(2):521-535. doi: 10.3233/JAD-170161.

The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials

Olsson B, Schott JM, Blennow K, Zetterberg H.

Expert Rev Neurother. 2017 Aug;17(8):767-775. doi: 10.1080/14737175.2017.1341311. Epub 2017 Jun 19.

Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products

Yi L, Liu W, Wang Z, Ren D, Peng W.

Ann N Y Acad Sci. 2017 Jun;1398(1):130-141. doi: 10.1111/nyas.13385. Epub 2017 Jun 20.

[Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients]

Asai M, Kawakubo T, Mori R, Iwata N.

Yakugaku Zasshi. 2017;137(7):801-805. doi: 10.1248/yakushi.16-00236-2.

Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes

Cummings J.

Clin Transl Sci. 2018 Mar;11(2):147-152. doi: 10.1111/cts.12491. Epub 2017 Aug 2.

Potential Roles of Exosomal MicroRNAs as Diagnostic Biomarkers and Therapeutic Application in Alzheimer's Disease

Chen JJ, Zhao B, Zhao J, Li S.

Neural Plast. 2017;2017:7027380. doi: 10.1155/2017/7027380. Epub 2017 Jul 9.

[Alzheimer's disease from Auguste Deter to the present : Progress, disappointments and open questions]

Pantel J.

Z Gerontol Geriatr. 2017 Oct;50(7):576-587. doi: 10.1007/s00391-017-1307-2. Epub 2017 Sep 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias